Table of Contents
2019-2024 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption 2014-2024
2.1.2 Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2014-2019)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2014-2019)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2014-2019)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2014-2019)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value and Market Share by Application (2014-2019)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2014-2019)
3 Global Neuromodulation Devices and Implantable Infusion Pumps by Players
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Players
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Players (2017-2019)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Players (2017-2019)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Players
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Players (2017-2019)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Players (2017-2019)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Players
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion
4 Neuromodulation Devices and Implantable Infusion Pumps by Regions
4.1 Neuromodulation Devices and Implantable Infusion Pumps by Regions
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value by Regions
4.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.5 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
5 Americas
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Countries
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East and Africa
8.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps by Countries
8.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
8.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
8.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
10.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast
11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast (2019-2024)
11.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions
11.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions (2019-2024)
11.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
11.8 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application
12 Key Players Analysis
12.1 Medtronic
12.1.1 Company Details
12.1.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Medtronic News
12.2 Boston Scientific Corporation
12.2.1 Company Details
12.2.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Boston Scientific Corporation News
12.3 St. Jude Medical
12.3.1 Company Details
12.3.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 St. Jude Medical News
12.4 Synapse Biomedical
12.4.1 Company Details
12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Synapse Biomedical News
12.5 Nevro Corporation
12.5.1 Company Details
12.5.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Nevro Corporation News
12.6 Neuropace
12.6.1 Company Details
12.6.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Neuropace News
12.7 Cyberonics
12.7.1 Company Details
12.7.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Cyberonics News
12.8 Autonomic Technologies
12.8.1 Company Details
12.8.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Autonomic Technologies News
12.9 Avery Biomedical
12.9.1 Company Details
12.9.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Avery Biomedical News
12.10 Greatbatch Medical
12.10.1 Company Details
12.10.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Greatbatch Medical News
13 Research Findings and Conclusion
